Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Neos Theraps Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NEOS THERAPS, and what generic alternatives to NEOS THERAPS drugs are available?

NEOS THERAPS has three approved drugs.

There are six US patents protecting NEOS THERAPS drugs.

There are two patent family members on NEOS THERAPS drugs in two countries.

Summary for Neos Theraps

International Patents:	2
US Patents:	6
Tradenames:	3
Ingredients:	2
NDAs:	3

Drugs and US Patents for Neos Theraps

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Neos Theraps Inc	COTEMPLA XR-ODT	methylphenidate	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	205489-003	Jun 19, 2017		RX	Yes	Yes	9,089,496	⤷ Try it Free	Y			⤷ Try it Free
Neos Theraps	ADZENYS XR-ODT	amphetamine	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	204326-002	Jan 27, 2016		RX	Yes	No	9,017,731	⤷ Try it Free	Y			⤷ Try it Free
Neos Theraps	ADZENYS XR-ODT	amphetamine	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	204326-003	Jan 27, 2016		RX	Yes	No	8,709,491	⤷ Try it Free	Y			⤷ Try it Free
Neos Theraps	ADZENYS XR-ODT	amphetamine	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	204326-005	Jan 27, 2016		RX	Yes	No	9,265,737	⤷ Try it Free	Y			⤷ Try it Free
Neos Theraps	ADZENYS XR-ODT	amphetamine	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	204326-001	Jan 27, 2016		RX	Yes	No	9,265,737	⤷ Try it Free	Y			⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Neos Theraps Drugs

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration
European Patent Office	2726066	⤷ Try it Free
World Intellectual Property Organization (WIPO)	2013003622	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Baxter

Johnson and Johnson

McKesson

Express Scripts

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.